- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02636257
A Comparative Study of Two Endoscopic Operations for Lacrimal Duct Obstruction (ACSOTEOFLDO)
October 10, 2017 updated by: Deng Huiyi, Third Affiliated Hospital, Sun Yat-Sen University
A Comparative Study of Recessive Spherical Headed Silicone Intubation and Dacryocystorhinostomy Under Nasal Endoscopy in the Treatment of Nasolacrimal Duct Obstruction
To compare the clinical effects between the silicone nasolacrimal intubation under nasoendoscopy and dacryocystorhinostomy on patients with lacrimal duct obstruction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Lacrimal duct obstruction is common among patients with epiphora,which is seriously affect the quality of life.
The treatment principle is to restore or rebuild the lacrimal duct drainage channel.
The classic operation type is dacryocystorhinostomy(DCR), which is complex for face-section particularly.
However, with the development of endoscopy, the investigators prefer to the silicone nasolacrimal intubation under nasal endoscopy, which is more simple and efficient.
With endoscopy, the investigators can see anatomical structures clearly and then can perform the operation much more perfectly.Compare to the classic one called DCR, its short and long term therapeutic effects are equal and even better.Therefore,the latter type does do good to both doctors and patients.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510630
- ThirdSunYatSen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Nasolacrimal Duct Obstruction based on a clinical of epiphora and purulent secretion, another punctiform orifices with reflux in subsequent flushing in lacrimal passage irrigation;
- Must be able to withstand surgery
- At least 18 years old
- NO lacrimal tumor and acute inflammation
- Nasolacrimal duct obstruction in digital subtraction dacryocystography
- A sufficient level of education to understand study procedures and be able to communicate with site personnel and adhere to the follow-up;
- Accepted informed consent verbally and in writing
Exclusion Criteria:
- The Poor Health
- Be allergic to anesthetics
- Lacrimal duct abnormalities
- Lacrimal tumor and acute inflammation
- Children
- The same Surgery failure before
Exit Criteria
- Postoperative infection and persistent inflammation
- Operation failure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Recessive Spherical Headed Silicone Intubation
The silicone nasolacrimal intubation under nasal endoscopy can restore natural drainage pathway in tears and as an out-patient surgery, it is more simple,cheap and mini-invasive.Recessive Spherical Headed Silicone Intubation is safe,convenient and almost unpainful for no trauma.It has no facial scar and no damage for structure and function of lacrimal duct.Besides,silica gel is non-toxic and nonirritating.Nasal endoscopy handed by otorhinolaryngologist helps intraoperative visualization about anatomy of the nasal cavity,understanding and management of congenital nasolacrimal duct obstruction and is the only method that confirms the correct anatomic position of the catheterization and in real time,avoiding traditionally the blind raking-out wire by the ophthalmologist alone.Compare to the classic DCR,its short therapeutic effects are equal but more convenient and fewer time and money-cost.
|
Local anesthesia,regular disinfection, spread sterile towels, exposure operative side.2%lidocaine
infiltration anesthesia to inferior orbital nerves, lacrimal punctum and lacrimal sac.
Nasal cavity was packed with gauze soaked in 2%ephedrine with 1%tetracaine 15 minutes before procedure.A routine silicone tube of spherical intubation was performed.
Dilatated lacrimal point to the end, then inserted the probe with line from lacrimal punctum to inferior meatus through nasolacrimal duct.Cut the line and flush the lacrimal duct physiological saline in 5 mL, flowing the line into the inferior meatus, then suctioned out the line with nasal endoscopy and extracted the probe and dilatated the lacrimal duct again.
Insert the spherical silicone tube from lacrimal point to the lacrimal sac, reversing to vertical direction to ensure the tube is inserted into the nasolacrimal duct, then catch the above line but cut short the follow one and fix.Unobstructed lacrimal irrigation.
|
OTHER: Dacryocystorhinostomy
Nasolacrimal duct obstruction is common among patients with epiphora,which is seriously affect the quality of life.
The treatment principle is to restore or rebuild the lacrimal duct drainage channel.
The classic operation type is dacryocystorhinostomy(DCR), which is complex for face-section particularly.After surgery the lacrimal passage can't siphon the tear out physically any more so that it will effect the patients' life.Besides,the operating time,bleeding volume,hospitalization time and total cost for the surgery is higher.
|
Surgery was performed under local anesthesia.Incision was taken over anterior lacrimal crest.Medial palpebral ligament was identified.Orbicularis was separated.Reflection of periosteum and dissection of lacrimal sac from lacrimal fossa was done.Sac was excised to make'H'shaped anterior and posterior flaps.
Bony osteum of sufficient size was made with bone punch.Nasal mucosa was cut to make anterior and posterior flaps.Subsequently anterior to anterior and posterior to posterior flaps were sutured.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Epiphora Improvement
Time Frame: one-year follow-up
|
Cure:postoperative epiphora disappeared.
Effective:clinical symptom remission.
Invalid:no effect on epiphora.
|
one-year follow-up
|
Lacrimal Passage Irrigation
Time Frame: one-year follow-up
|
Cure:no reflux after lacrimal passage irrigation.
Effective:a little reflux after lacrimal passage irrigation.
Invalid:a lot reflux after lacrimal passage irrigation.
|
one-year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative Visual Analogue Scale (VAS)
Time Frame: Six times in one-year follow-up,respectively,immediate post-surgical,the 1th week,the 1th month,the 3rd month,the 6th month and the 12th month after the surgery.
|
From 0 to 10 according to the patients' feeling and life quality
|
Six times in one-year follow-up,respectively,immediate post-surgical,the 1th week,the 1th month,the 3rd month,the 6th month and the 12th month after the surgery.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bleeding volume in milliliter during the surgery
Time Frame: one-year follow-up
|
The surgeon records the cadaverine quantity of bleeding
|
one-year follow-up
|
Operating time in minutes
Time Frame: one-year follow-up
|
Recessive Spherical Headed Silicone Intubation Under Nasal Endoscopy was from dilatation to unobstructed lacrimal irrigation.Dacryocystorhinostomy was from flap incision to packing.
|
one-year follow-up
|
hospitalization time in hours
Time Frame: one-year follow-up
|
From admission formalities to leave hospital
|
one-year follow-up
|
total cost on the treatment in yuan
Time Frame: one-year follow-up
|
From admission formalities to leave hospital
|
one-year follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Yang Qintai, director, Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510630, Guangdong, Peoples R China.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- McDonogh M, Meiring JH. Endoscopic transnasal dacryocystorhinostomy. J Laryngol Otol. 1989 Jun;103(6):585-7. doi: 10.1017/s0022215100109405.
- Onerci M, Orhan M, Ogretmenoglu O, Irkec M. Long-term results and reasons for failure of intranasal endoscopic dacryocystorhinostomy. Acta Otolaryngol. 2000 Mar;120(2):319-22. doi: 10.1080/000164800750001170.
- Wormald PJ. Powered endoscopic dacryocystorhinostomy. Laryngoscope. 2002 Jan;112(1):69-72. doi: 10.1097/00005537-200201000-00013.
- Saroj G, Rashmi G. Conventional dacryocystorhinostomy versus endonasal dacryocystorhinostomy-a comparative study. Indian J Otolaryngol Head Neck Surg. 2010 Sep;62(3):296-8. doi: 10.1007/s12070-010-0087-4. Epub 2010 Oct 12.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2015
Primary Completion (ACTUAL)
January 1, 2017
Study Completion (ACTUAL)
January 1, 2017
Study Registration Dates
First Submitted
December 9, 2015
First Submitted That Met QC Criteria
December 16, 2015
First Posted (ESTIMATE)
December 21, 2015
Study Record Updates
Last Update Posted (ACTUAL)
October 11, 2017
Last Update Submitted That Met QC Criteria
October 10, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SYSU-5010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lacrimal Duct Obstruction
-
Tehran University of Medical SciencesUnknownCongenital Nasolacrimal Duct ObstructionIran, Islamic Republic of
-
Rutgers, The State University of New JerseyBausch & Lomb IncorporatedCompletedCongenital Nasolacrimal Duct ObstructionUnited States
-
Cairo UniversityUnknownCongenital Nasolacrimal Duct ObstructionEgypt
-
Menoufia UniversityCompletedPrimary Acquired Nasolacrimal Duct Obstruction
-
Western Galilee Hospital-NahariyaUnknownAcquired Nasolacrimal Duct ObstructionIsrael
-
Cathay General HospitalCompletedCongenital Nasolacrimal Duct ObstructionTaiwan
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedNasolacrimal Duct ObstructionUnited States
-
University Hospital OstravaCompletedNasolacrimal Duct ObstructionCzech Republic
-
University of British ColumbiaCompletedNasolacrimal Duct ObstructionCanada
-
Instituto de Oftalmología Fundación Conde de ValencianaRecruitingDacryocystorhinostomy | Nasolacrimal Duct ObstructionMexico
Clinical Trials on Recessive Spherical Headed Silicone Intubation
-
University Hospital OstravaCompletedNasolacrimal Duct ObstructionCzech Republic
-
Tianjin Eye HospitalCompletedLacrimal Duct ObstructionChina
-
Ajou University School of MedicineCompletedIntubation;DifficultKorea, Republic of
-
Menoufia UniversityCompletedPrimary Acquired Nasolacrimal Duct Obstruction